This resistance often emerges in metastatic tumours, because cancer cells can evolve in ways that allow them to survive, such ...

Panelists discuss the role of molecular testing in metastatic non–-small cell lung cancer (NSCLC), emphasizing its importance in identifying actionable mutations and guiding personalized treatment ...

Diagnosed with stage 3B lung cancer in 2018, I joined a support group where I met Jim and Melanie, and learned about Jim's ...

Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTS™ ...

Yibin Kang, a professor in the Department of Molecular Biology, discussed new breast cancer research in his lab.

Genprex’s (GNPX) research collaborators at a major cancer research center in Houston, Texas have published a new study which used the company’s ...

Metastases can occur many years after primary cancer treatment ... circulation through the heart to the capillaries of the lung, and access to the arterial circulation (and other organs of ...

New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

Brain metastases are one of the most severe complications of melanoma, the most aggressive type of skin cancer. Researchers ...

Enhertu (fam-trastuzumab deruxtecan-nxki) has received FDA approval for HR-positive, HER2-low, HER2-ultralow metastatic breast cancer.

One of the biggest challenges in cancer treatment is addressing the ability of cancer cells to adapt and become resistant, ...